Researchers in Whitehead Institute Member Robert Weinberg’s lab identified two molecules active in cancer stem cells that control whether the cells can form new tumors.
Family trees of lung cancer cells, built using CRISPR-based lineage tracing, reveal in depth how cancer evolves from its earliest stages to become aggressive and capable of spreading throughout the body.
New research from the lab of Whitehead Institute Founding Member Robert Weinberg shows that cells change in diverse ways through the actions of the epithelial-mesenchymal transition, which can influence whether cells are able to form new tumors after they spread.
Work on HIV’s RNA structure and the compartmentalization of cancer drugs are in the running as part of STAT News’ annual single-elimination March Madness-style research competition
Using CRISPR technology, Whitehead Institute Member Jonathan Weissman is tracking the lineage of individual cancer cells as they proliferate and metastasize in real time.
Researchers in the lab of Whitehead Institute Founding Member Robert Weinberg have determined how mesenchymal cancer cells may resist treatment, work that may allow them to make once-resistant tumors respond to certain cancer therapies.
